Study Finds Russia’s COVID-19
Vaccine to Be Highly Effective
Against Brazilian Variant.
Researchers in Argentina have tested Russia’s COVID-19
vaccine, Sputnik V, against Brazil’s P1 variant. .
The study was conducted by the Dr. Vanella Institute of
Virology of the National University of Córdoba (UNC).
The Argentinian researchers found that
those inoculated with Sputnik V had a strong
immune response against the variant. .
85.5 percent of individuals developed
antibodies against the variant two weeks after
receiving their first vaccine dose. .
Nearly 100 percent of individuals developed antibodies
by day 42 - after receiving their second vaccine dose.
Russia's Direct Investment Fund (RDIF)
cited the study in a statement, saying it “confirmed”
the immunity offered by Sputnik V. .
The study confirmed that the immunity
developed in people vaccinated with
'Sputnik V' neutralizes the Brazilian
strain after having received two doses,
and even after the first, RDIF, via Reuters.
According to Rogelio Pizzi, dean of the
Faculty of Medical Sciences of the UNC, they are
also conducting studies involving the U.K. strain.